查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1743730

獸醫靜脈注射解決方案市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、適應症、動物類型、最終用途、地區和競爭細分，2020-2030 年

Veterinary Intravenous Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Animal type, By End Use, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球獸醫靜脈注射 (IV) 解決方案市場規模達13.5億美元，預計將大幅擴張，到2030年將達到新高，預測期內的複合年成長率為6.57%。這一成長反映了獸醫學的進步，也反映了人類醫療保健的趨勢，其中靜脈注射解決方案已成為治療方案中不可或缺的一部分。獸醫靜脈注射解決方案對於各種動物的補液、藥物輸送和重症監護都至關重要。全球寵物擁有量的增加、人們對動物照護期望值的提高以及投保寵物數量的增加（例如，2024年北美報告的投保寵物數量為625萬隻）是推動這一需求激增的主要因素。這些解決方案可用於常規和緊急情況，在獸醫環境中支持復健和治療效果。隨著人類與動物之間聯繫的加深以及寵物護理的日益複雜，對可靠、有效的靜脈注射療法的需求持續成長，推動著全球市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 13.5億美元
2030年市場規模 19.6億美元
2025-2030 年複合年成長率 6.57%
成長最快的領域 伴侶動物
最大的市場 北美洲

關鍵市場促進因素

寵物擁有量和人性化程度的提高正在推動全球獸醫靜脈注射（IV）解決方案市場的發展

主要市場挑戰

研究和配方種類有限對市場擴張構成重大障礙

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球獸醫靜脈注射（IV）解決方案市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（等滲晶體、合成膠體、血液製品、葡萄糖溶液、腸外營養）
    • 依適應症（糖尿病酮酸中毒、胰臟炎、炭疽病、慢性腎臟病、其他）
    • 依動物類型（伴侶動物、生產動物）
    • 依最終用途（獸醫院、研究機構、其他）
    • 按地區
    • 按公司分類（前五大市場參與者的股份）
  • 市場地圖
    • 按產品
    • 按適應症
    • 依動物類型
    • 按最終用途
    • 按地區

第6章：北美獸醫靜脈注射（IV）溶液市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第7章：歐洲獸用靜脈注射（IV）溶液市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第8章：亞太地區獸用靜脈注射（IV）解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第9章：南美洲獸醫靜脈注射（IV）溶液市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第 10 章：中東和非洲獸醫靜脈注射（IV）解決方案市場展望

  • 市場規模和預測
  • 市場佔有率和預測

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：競爭格局

  • Merck & Co., Inc.
  • Dechra Veterinary Products
  • Sypharma
  • Animalcare
  • B. Braun SE
  • Woods Consulting, LLC
  • Baxter International
  • Fresenius Kabi

第 14 章：策略建議

第15章調查會社について,免責事項

簡介目錄
Product Code: 16229

The Global Veterinary Intravenous (IV) Solutions Market was valued at USD 1.35 billion in 2024 and is projected to expand significantly, reaching new heights by 2030 with a CAGR of 6.57% during the forecast period. This growth reflects advancements in veterinary medicine, mirroring trends in human healthcare, where IV solutions are integral to treatment protocols. Veterinary IV solutions are crucial for hydration, medication delivery, and critical care across a variety of animal species. Increasing global pet ownership, heightened expectations for animal care, and the growing number of insured pets-such as the 6.25 million pets reported insured in North America in 2024-are major contributors to this surge in demand. These solutions are used in both routine and emergency situations, supporting recovery and treatment efficacy in veterinary settings. As the human-animal bond deepens and pet care becomes more sophisticated, the need for reliable, effective IV therapies continues to grow, driving market expansion worldwide.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.35 Billion
Market Size 2030USD 1.96 Billion
CAGR 2025-20306.57%
Fastest Growing SegmentCompanion Animal
Largest MarketNorth America

Key Market Drivers

Rising Pet Ownership and Humanization is Driving the Global Veterinary Intravenous (IV) Solutions Market

The rapid increase in global pet ownership and the growing trend of treating pets as family members are significantly boosting demand for veterinary healthcare services, including IV solutions. In the U.S., approximately 67% of households own a pet, a trend echoed in many other regions. This humanization of pets has transformed the way owners approach healthcare, prompting greater interest in advanced medical treatments similar to those used for humans. Veterinary IV solutions, vital for administering fluids, medications, and nutrients during critical care, are increasingly in demand as pet owners seek comprehensive and high-quality medical support. The surge in pet insurance coverage also supports this growth by making advanced veterinary treatments more financially accessible, encouraging more pet owners to opt for intensive interventions that include IV therapy.

Key Market Challenges

Limited Research and Formulation Variety Poses a Significant Obstacle To Market Expansion

A significant challenge facing the veterinary IV solutions market is the limited research and formulation diversity tailored to various animal species. Unlike human IV solutions, which benefit from extensive R&D and specificity, veterinary formulations often lack the same level of customization. This is particularly problematic for exotic and less common species that have unique physiological needs not addressed by standard formulations. The limited number of species-specific products restricts veterinarians' ability to deliver optimal care, which can impact treatment outcomes. This gap in product variety hinders market expansion and highlights the need for increased investment in research to develop a broader range of targeted IV solutions across diverse animal categories.

Key Market Trends

Technological Advancements

The integration of precision medicine and digital health technologies is reshaping the veterinary IV solutions market. Diagnostic innovations, such as genetic testing, allow for the formulation of personalized IV therapies, improving treatment effectiveness and patient outcomes. Telemedicine platforms and remote monitoring tools are also revolutionizing care delivery, enabling veterinarians to track patient vitals and modify IV regimens in real time without in-person visits. Moreover, smart infusion pumps and automated delivery systems enhance accuracy and safety by precisely controlling fluid and medication administration. These systems can adapt dosages dynamically based on live data. The adoption of digital health records and analytics further supports data-driven treatment decisions, improving care outcomes and contributing to the evolution of more targeted, efficient, and intelligent veterinary healthcare protocols.

Key Market Players

  • Merck & Co., Inc.
  • Dechra Veterinary Products
  • Sypharma Pty Ltd.
  • Animalcare group plc
  • Braun SE
  • Woods Consulting, LLC
  • Baxter International
  • Fresenius Kabi

Report Scope:

In this report, the Global Veterinary Intravenous (IV) Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Intravenous (IV) Solutions Market, By Product:

  • Isotonic crystalloids
  • Synthetic colloids
  • Blood products
  • Dextrose solutions
  • Parenteral nutrition

Veterinary Intravenous (IV) Solutions Market, By Indication:

  • Diabetic Ketoacidosis
  • Pancreatitis
  • Anthrax
  • Chronic Kidney Disease
  • Others

Veterinary Intravenous (IV) Solutions Market, By Animal Type:

  • Companion Animals
  • Production Animals

Veterinary Intravenous (IV) Solutions Market, By End Use:

  • Veterinary Hospitals
  • Research Institutes
  • Others

Veterinary Intravenous (IV) Solutions Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Intravenous (IV) Solutions Market.

Available Customizations:

Global Veterinary Intravenous (IV) Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Intravenous (IV) Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition)
    • 5.2.2. By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others)
    • 5.2.3. By Animal type (Companion Animals, Production Animals)
    • 5.2.4. By End Use (Veterinary Hospitals, Research Institutes, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (Shares of Top 5 Market Players)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Indication
    • 5.3.3. By Animal type
    • 5.3.4. By End Use
    • 5.3.5. By Region

6. North America Veterinary Intravenous (IV) Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Animal type
    • 6.2.4. By End Use
    • 6.2.5. By Country
      • 6.2.5.1. United States Veterinary Intravenous (IV) Solutions Market Outlook
        • 6.2.5.1.1. Market Size & Forecast
        • 6.2.5.1.1.1. By Value
        • 6.2.5.1.2. Market Share & Forecast
        • 6.2.5.1.2.1. By Product
        • 6.2.5.1.2.2. By Indication
        • 6.2.5.1.2.3. By Animal type
        • 6.2.5.1.2.4. By End Use
      • 6.2.5.2. Canada Veterinary Intravenous (IV) Solutions Market Outlook
        • 6.2.5.2.1. Market Size & Forecast
        • 6.2.5.2.1.1. By Value
        • 6.2.5.2.2. Market Share & Forecast
        • 6.2.5.2.2.1. By Product
        • 6.2.5.2.2.2. By Indication
        • 6.2.5.2.2.3. By Animal type
        • 6.2.5.2.2.4. By End Use
      • 6.2.5.3. Mexico Veterinary Intravenous (IV) Solutions Market Outlook
        • 6.2.5.3.1. Market Size & Forecast
        • 6.2.5.3.1.1. By Value
        • 6.2.5.3.2. Market Share & Forecast
        • 6.2.5.3.2.1. By Product
        • 6.2.5.3.2.2. By Indication
        • 6.2.5.3.2.3. By Animal type
        • 6.2.5.3.2.4. By End Use

7. Europe Veterinary Intravenous (IV) Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Animal type
    • 7.2.4. By End Use
    • 7.2.5. By Country
      • 7.2.5.1. France Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.1.1. Market Size & Forecast
        • 7.2.5.1.1.1. By Value
        • 7.2.5.1.2. Market Share & Forecast
        • 7.2.5.1.2.1. By Product
        • 7.2.5.1.2.2. By Indication
        • 7.2.5.1.2.3. By Animal type
        • 7.2.5.1.2.4. By End Use
      • 7.2.5.2. Germany Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.2.1. Market Size & Forecast
        • 7.2.5.2.1.1. By Value
        • 7.2.5.2.2. Market Share & Forecast
        • 7.2.5.2.2.1. By Product
        • 7.2.5.2.2.2. By Indication
        • 7.2.5.2.2.3. By Animal type
        • 7.2.5.2.2.4. By End Use
      • 7.2.5.3. United Kingdom Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.3.1. Market Size & Forecast
        • 7.2.5.3.1.1. By Value
        • 7.2.5.3.2. Market Share & Forecast
        • 7.2.5.3.2.1. By Product
        • 7.2.5.3.2.2. By Indication
        • 7.2.5.3.2.3. By Animal type
        • 7.2.5.3.2.4. By End Use
      • 7.2.5.4. Italy Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.4.1. Market Size & Forecast
        • 7.2.5.4.1.1. By Value
        • 7.2.5.4.2. Market Share & Forecast
        • 7.2.5.4.2.1. By Product
        • 7.2.5.4.2.2. By Indication
        • 7.2.5.4.2.3. By Animal type
        • 7.2.5.4.2.4. By End Use
      • 7.2.5.5. Spain Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.5.1. Market Size & Forecast
        • 7.2.5.5.1.1. By Value
        • 7.2.5.5.2. Market Share & Forecast
        • 7.2.5.5.2.1. By Product
        • 7.2.5.5.2.2. By Indication
        • 7.2.5.5.2.3. By Animal type
        • 7.2.5.5.2.4. By End Use

8. Asia Pacific Veterinary Intravenous (IV) Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Animal type
    • 8.2.4. By End Use
    • 8.2.5. By Country
      • 8.2.5.1. China Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.1.1. Market Size & Forecast
        • 8.2.5.1.1.1. By Value
        • 8.2.5.1.2. Market Share & Forecast
        • 8.2.5.1.2.1. By Product
        • 8.2.5.1.2.2. By Indication
        • 8.2.5.1.2.3. By Animal type
        • 8.2.5.1.2.4. By End Use
      • 8.2.5.2. India Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.2.1. Market Size & Forecast
        • 8.2.5.2.1.1. By Value
        • 8.2.5.2.2. Market Share & Forecast
        • 8.2.5.2.2.1. By Product
        • 8.2.5.2.2.2. By Indication
        • 8.2.5.2.2.3. By Animal type
        • 8.2.5.2.2.4. By End Use
      • 8.2.5.3. South Korea Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.3.1. Market Size & Forecast
        • 8.2.5.3.1.1. By Value
        • 8.2.5.3.2. Market Share & Forecast
        • 8.2.5.3.2.1. By Product
        • 8.2.5.3.2.2. By Indication
        • 8.2.5.3.2.3. By Animal type
        • 8.2.5.3.2.4. By End Use
      • 8.2.5.4. Japan Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.4.1. Market Size & Forecast
        • 8.2.5.4.1.1. By Value
        • 8.2.5.4.2. Market Share & Forecast
        • 8.2.5.4.2.1. By Product
        • 8.2.5.4.2.2. By Indication
        • 8.2.5.4.2.3. By Animal type
        • 8.2.5.4.2.4. By End Use
      • 8.2.5.5. Australia Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.5.1. Market Size & Forecast
        • 8.2.5.5.1.1. By Value
        • 8.2.5.5.2. Market Share & Forecast
        • 8.2.5.5.2.1. By Product
        • 8.2.5.5.2.2. By Indication
        • 8.2.5.5.2.3. By Animal type
        • 8.2.5.5.2.4. By End Use

9. South America Veterinary Intravenous (IV) Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Animal type
    • 9.2.4. By End Use
    • 9.2.5. By Country
      • 9.2.5.1. Brazil Veterinary Intravenous (IV) Solutions Market Outlook
        • 9.2.5.1.1. Market Size & Forecast
        • 9.2.5.1.1.1. By Value
        • 9.2.5.1.2. Market Share & Forecast
        • 9.2.5.1.2.1. By Product
        • 9.2.5.1.2.2. By Indication
        • 9.2.5.1.2.3. By Animal type
        • 9.2.5.1.2.4. By End Use
      • 9.2.5.2. Argentina Veterinary Intravenous (IV) Solutions Market Outlook
        • 9.2.5.2.1. Market Size & Forecast
        • 9.2.5.2.1.1. By Value
        • 9.2.5.2.2. Market Share & Forecast
        • 9.2.5.2.2.1. By Product
        • 9.2.5.2.2.2. By Indication
        • 9.2.5.2.2.3. By Animal type
        • 9.2.5.2.2.4. By End Use
      • 9.2.5.3. Colombia Veterinary Intravenous (IV) Solutions Market Outlook
        • 9.2.5.3.1. Market Size & Forecast
        • 9.2.5.3.1.1. By Value
        • 9.2.5.3.2. Market Share & Forecast
        • 9.2.5.3.2.1. By Product
        • 9.2.5.3.2.2. By Indication
        • 9.2.5.3.2.3. By Animal type
        • 9.2.5.3.2.4. By End Use

10. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Animal type
    • 10.2.4. By End Use
    • 10.2.5. By Country
      • 10.2.5.1. South Africa Veterinary Intravenous (IV) Solutions Market Outlook
        • 10.2.5.1.1. Market Size & Forecast
        • 10.2.5.1.1.1. By Value
        • 10.2.5.1.2. Market Share & Forecast
        • 10.2.5.1.2.1. By Product
        • 10.2.5.1.2.2. By Indication
        • 10.2.5.1.2.3. By Animal type
        • 10.2.5.1.2.4. By End Use
      • 10.2.5.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Outlook
        • 10.2.5.2.1. Market Size & Forecast
        • 10.2.5.2.1.1. By Value
        • 10.2.5.2.2. Market Share & Forecast
        • 10.2.5.2.2.1. By Product
        • 10.2.5.2.2.2. By Indication
        • 10.2.5.2.2.3. By Animal type
        • 10.2.5.2.2.4. By End Use
      • 10.2.5.3. UAE Veterinary Intravenous (IV) Solutions Market Outlook
        • 10.2.5.3.1. Market Size & Forecast
        • 10.2.5.3.1.1. By Value
        • 10.2.5.3.2. Market Share & Forecast
        • 10.2.5.3.2.1. By Product
        • 10.2.5.3.2.2. By Indication
        • 10.2.5.3.2.3. By Animal type
        • 10.2.5.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Merck & Co., Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Company Snapshot
    • 13.1.3. Products & Service
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Recent Developments
    • 13.1.6. Key Personnel Details
    • 13.1.7. SWOT Analysis
  • 13.2. Dechra Veterinary Products
  • 13.3. Sypharma
  • 13.4. Animalcare
  • 13.5. B. Braun SE
  • 13.6. Woods Consulting, LLC
  • 13.7. Baxter International
  • 13.8. Fresenius Kabi

14. Strategic Recommendations

15. About us & Disclaimer